The molecular mechanisms that underlie the neurological manifestations of patients with inherited diseases of vitamin B12 (cobalamin) metabolism remain to date obscure. We observed transcriptomic changes of genes involved in RNA metabolism and endoplasmic reticulum stress in a neuronal cell model with impaired cobalamin metabolism. These changes were related to the subcellular mislocalization of several RNA binding proteins, including the ELAVL1/HuR protein implicated in neuronal stress, in this cell model and in patient fibroblasts with inborn errors of cobalamin metabolism and Cd320 knockout mice. The decreased interaction of ELAVL1/HuR with the CRM1/exportin protein of the nuclear pore complex and its subsequent mislocalization resulted from hypomethylation at R-217 produced by decreased S-adenosylmethionine and protein methyl transferase CARM1 and dephosphorylation at S221 by increased protein phosphatase PP2A. The mislocalization of ELAVL1/HuR triggered the decreased expression of SIRT1 deacetylase and genes involved in brain development, neuroplasticity, myelin formation, and brain aging. The mislocalization was reversible upon treatment with siPpp2ca, cobalamin, S-adenosylmethionine, or PP2A inhibitor okadaic acid. In conclusion, our data highlight the key role of the disruption of ELAVL1/HuR nuclear export, with genomic changes consistent with the effects of inborn errors of Cbl metabolisms on brain development, neuroplasticity and myelin formation.
INTRODUCTION
Vitamin B12, (Cobalamin, Cbl) is essential for normal neurologic and hematologic development and function. However, the signalling pathway linking Cbl to the frequent neurological manifestations in diseases associated with errors of Cbl metabolism remains unidentified despite decades of intensive clinical and basic science investigations (1) . The clinical presentation includes megaloblastic anemia, mental retardation and encephalopathy in paediatric patients with the inborn errors (1) , and also peripheral neuropathy as well as other central nervous system (CNS) manifestations such as loss of memory and cognition, and dementia in Cbl deficient adult patients. Untreated, the neurologic sequelae can become permanent; therefore, a thorough understanding of the molecular mechanisms underlying the broad spectrum of symptoms is paramount for the enlargement of therapeutic options to these diseases (2) . In brain, cellular Cbl uptake is mediated by its binding in the form of Cbl-transcobalamin (TC) complex to CD320/TCBLR receptor (3, 4) . Once inside the cytoplasm, Cbl transforms into methylcobalamin (MeCbl) and serves as the cofactor for methionine synthase for de novo syn-thesis of methionine and its downstream production of S-adenosylmethionine (SAM) (2) . SAM is the universal methyl donor for methylation of DNA and key proteins involved in the control of gene expression (2, 5) . There are only a handful of adequate experimental models for detailed mechanistic studies to decipher the roles of Cbl in brain. Cd320 knockout mouse is a model with brain specific Cbl deficiency causing DNA hypomethylation (3, 6) . The TC-oleosin (TO) expressing strategy applied to cultured neuronal cells is another suitable model in which impaired Cbl metabolism can occur when cells overexpress TC-oleosin fusion protein (7) . Cbl sequestration is only possible when TC is attached to oleosin at N-terminal (TO) but not C-terminal of oleosin (OT) -as no binding of Cbl to OT (oleosin-TC) is possible (7) . Compared with WT mouse and OT cells, Cd320 KO and TO cells, respectively, show significantly lower methionine synthase activity and methylation potential (6, 8) .
Little is known of the signalling pathways associated with disrupted Cbl metabolism in brain. Methionine synthase reductase (Mtrr) mutation altered gene expression through decreased DNA methylation and induced tissue malformations including neural tube (9) . The nutritional model where Cbl and folate were both eliminated from food intake during pregnancy and lactation was shown to alter gene expressions in pups through imbalanced methylation and acetylation of nuclear receptors and their partner, PPAR␥ coactivator 1␣ (PGC1␣) (10) (11) (12) (13) (14) . Cbl impaired metabolism of the cultured TO neuroblastoma cells caused endoplasmic reticulum (ER) stress downstream of reduced SIRT1 expression (5) . The latter result is in line with the previous proteomic results from fibroblasts with inborn errors of Cbl metabolism; these cells show large-scale changes in protein expression in ER and in ubiquitin-proteasome system with UPR (unfolded protein response) and anti-oxidative stress functions (15) .
The presence of ER stress in cells deficient of Cbl may hold the key to understanding the Cbl-associated neurological manifestations as emerging evidences indicate that cellular stress can produce a subcellular mislocalization of RNA binding proteins (RBP) capable of disruption of mRNA processing, and lead to neurological diseases and brain ageing (16) (17) (18) . Phosphorylation and methylation changes in RBPs such as ELAVL1/HuR, hnRNPA1 (heterogeneous nuclear ribonucleoprotein A1), SRSF1 (serine/argininerich splicing factor 1) and Y14 (RNA Binding Motif Protein 8A) are part of the mechanisms that regulate the nucleocytoplasmic transport of mRNAs in cancer cells and in replicative senescence (19, 20) .
Our goal was thus to determine whether the neuropathological outcomes of inborn errors of Cbl metabolism are the consequences of dysregulated subcellular distribution of RBP. To address this issue, we examined three experimental models carrying compromised cellular Cbl metabolism, TO/OT N1E115 cells, Cd320 KO mouse, and fibroblasts from patients with inherited defects leading to reduced methionine synthase activity. The evidence presented herein revealed that Cbl influences mRNA nucleocytoplasmic transport through controlling subcellular localization of RBPs, in particular on ELAVL1/HuR, by altering their methylation and phosphorylation status.
MATERIALS AND METHODS
Cell culture and siRNA/plasmid transfections N1E115 cell culture protocol and stable transfection of TO and OT chimeric proteins was as described previously (8) . Details are provided in supplementary methods. In experiments where siRNAs (siElavl1, siPpp2ca, siCarm1 and control siRNA) were used, the siRNAs were obtained from Life technologies (Saint Aubin, France). The sequences and details of transfection are given in supplementary methods. We used the pcDNA3-ELAVL1/HuR-cFLAG (gifted by Dr J.A. Steitz, Yale University) as the template for the creation of ELAVL1/HuR mutations using the QuickChange Lightning Site-Directed Mutagenesis kit (Agilent Technologies; see supplementary methods for details). Cell culture of patient and control fibroblasts was performed as described (21) .
Preparation of separate nuclear and cytoplasmic lysates
The separation of nuclear and cytoplasmic lysates was performed using Paris kit (Ambion, Life technologies). This kit was used according to the manufacturer's instructions.
Western blot
To prepare cell lysate, live cells or frozen mouse tissues were lysed directly with a solution containing sodium phosphate anhydrous dibasic, potassium dihydrogen phosphate, 150 mM NaCl, 1% Nonidet P40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate and Complete Protease Inhibitors (Roche, Boulogne-Billancourt, France). Lysates were then subjected to centrifugation at 12 000 rpm for 30 min. The protein concentration of the supernatant was determined using BCA Protein Assay kit (Pierce, Brebieres, France) and BSA as standard protein. In general, 40 g of the total protein was loaded per lane for SDS-PAGE. Proteins from lysates were electro-transferred onto PVDF membranes; the latters were then processed by incubation with primary and secondary antibodies as described in supplementary methods. The protein bands were quantified densitometrically, normalized with ␤-actin, and expressed as arbitrary units.
Immunoflorescence
Neuroblastoma cells. N1E115 cells were grown on slides for 48 h, then fixed with 4% paraformaldehyde for 10 min at 4
• C and blocked with 3% BSA overnight. Cells were incubated with various primary antibodies as described in supplementary methods. The immunostained cells were imaged using Nikon C2 confocal microscope equipped with three laser lines (405, 488 and 543 nm). The images were obtained with 60x oil immersion lens. CD320 mice. The inactivation of the transcobalamin receptor (CD320 KO) in mouse produced an impaired uptake of Cbl in the CNS (4, 6) . Sagittal brain sections (paraffin) were processed as described previously in the immunofluorescence-Neuroblastoma cells section (supplementary methods).
Duolink (proximity ligation assay, PLA)
The proximity ligation assay (PLA; Duolink in situ PLA reagents; Olink Bioscience; Eurogentec, France) was performed to visualize and quantify interactions, as described previously (11, 21) . The PLA signals were counted as described in supplementary methods.
FISH staining
Neuroblastoma cells were grown on slides for 48 h, fixed with 4% paraformaldehyde and permeabilized with PBS-0.1% triton. A prehybridization was performed followed by the hybridization; FISH probes were obtained from Eurogentec (Angers, France). The cells were imaged using Nikon C2. The detailed procedure is described in supplementary methods.
ImmunoPrecipitation (IP)
Live cells or minced frozen mouse brain tissues from hippocampus and striatum were lysed directly with the IP lysis/Wash buffer. The total protein used per IP reaction (500 g) was combined with 5 g of affinity purified antibody and incubated overnight at 4
• C to form the immune complex. This complex was added to the resin Protein (Thermo Scientific). After centrifugation followed by four washes with lysis/wash buffer, the final pellet was combined with laemmli buffer and loaded onto SDS-PAGE gel for separation via electrophoresis. Immunoblottings were then obtained by procedures as described in supplementary methods.
Ribonucleoprotein immunoprecipitation (RIP)
The preparation of the immune complex (ELAVL1/HuR complex) was performed as described previously in the immunoprecipitation section above. Instead of adding laemmli buffer, 150 l IP lysis/Wash buffer, 7.5 l SDS 20% and 18 l Proteinase K (10 mg/ml) were added to the resin. This mixture was incubated for 30 min at 55
• C with rotary agitation. Then a phenol-chloroform extraction was performed. Reverse transcription was done on the RNA by using the iScript cDNA Synthesis System (Bio-Rad, Marnesla-Coquette, France) Quantitect Reverse Transcription kit (Qiagen, Paris, France). Quantitative PCR was performed as described in supplementary methods.
Animals
The null Cd320 KO mice were produced locally by cross breeding heterozygous C57BL/6 N strain mice transported to France from SUNY Downstate Medical Center (Brooklyn, New York). The animal experiments were all performed in animal facilities authorized to carry out experimentation and followed the Directive 2010/63/EU revising the directive 86/609/EEC on the protection of animals used for scientific purposes.
Transcriptome
RNA was purified and hybridized on Agilent 44k Array as described in supplementary methods (22) .
Statistics
Data were analyzed with Stata 12.0 software (StataCorp, College Station, TX, USA) and reported as means ± S.E. Data were compared by one-way analysis of variance (ANOVA) with Fisher's test. We assigned a number of determination per study groups of cell (n = 8 in each group) and animal experiments (12 males and 12 females), which corresponded to a study power calculation based on a 2-fold difference between groups, with 1-␤ = 0.8 and ␣ = 0.05. A P-value 0.05 was considered to indicate statistical significance. Results were denoted by asterisks in figures (*P < 0.05; **P < 0.01 and ***P < 0.001).
Study approval
We obtained the approval of the ethical committee for animal experiments of the region Lorraine to perform the animal study in CD320 mice (agreement # 5454722).
RESULTS
The impaired cellular Cbl availability produced dramatic transcriptomic changes associated with mislocalization of RNA binding proteins in TO and OT cells cultured in the presence of endoplasmic reticulum stress inducer G418
Reduced Cbl cellular availability influenced considerably the transcriptome of the cell model studied (TO versus OT cells; Supplementary Table S1 and S2 and Supplementary Figures S1 and S2). Metabolic processing of RNA, cellular response to stress, regulation of cell cycle, neurogenesis, neuron differentiation, neuroplasticity and neuron development were among the top molecular and cellular functions affected (Supplementary Table S1 and S2). Some of these changes were related to neuroplasticity, including altered expression in dopaminergic, GABAergic, serotonergic and cholinergic synapses (Supplementary Figure  S1 ). The prominent changes related to metabolic processing of RNA and cellular response to stress led us to investigate potential deregulation of RNA transport mediated by RBPs, including ELAVL1/HuR, hnRNPA1, Y14, SRSF1 (also named ASF/SF2), FMRP, TDP43, and MLN51 (Figure 1 and Supplementary Figure S3 ). The transfected TO and OT cells were cultivated in the presence of G418. This aminoglycoside is used to maintain the expression of the neo gene to ensure stable transgene expression; it produces ER stress. We studied thus the effect of G418 on nontransfected N1E115 cells. The introduction of G418 in culture medium targeted ELAVL1/HuR into cytoplasm in both non-transfected N1E115 cells and OT control cells ( Figures 1 and 2A) ; interestingly, G418 also caused a limited amount of hnRNPA1 shuttling into cytoplasm in control OT cells, but it had no effect on the nuclear localization of Y14 and SRSF1 ( Figure 1A ). In TO cells with the presence of G418, its Cbl deficiency blocked ELAVL1/HuR export and caused cytoplasmic retention of hnRNPA1, Y14 and SRSF1 ( Figure 1A and SRSF1 to localize to the same subcellular compartment as that observed in TO cells ( Figure 1A ). The mislocalization detected by immunofluorescence was later confirmed by Western blots ( Figure 1B and Supplementary Figure  S4 ). Western blots of the immunoprecipitated RBPs showed equally less arginine methylation and serine phosphorylation of ELAVL1/HuR, hnRNPA1, Y14 and SRSF1 in TO versus OT cells ( Figure 1C and Supplementary Figure S4) . Indeed, we found decreased expressions of CARM1 and PKCs, the enzymes involved in arginine methylation and serine phosphorylation of these RBPs, and an increased expression of PP2A phosphatase in TO versus OT cells (Figure 1D and Supplementary Figures S4 and S6 ). Taken together, our data showed that impaired Cbl availability caused subcellular mislocalization and decreased arginine-methylation and serine-phosphorylation of RBPs, with ELAVL1/HuR as the most affected RBP in TO versus OT cells exposed to G418.
The mislocalization of RNA binding proteins was also observed in fibroblasts of patient with inborn errors of Cbl metabolism and in Cd320 KO mice
In control wild type fibroblasts, we found ELAVL1/HuR localized exclusively to the nucleus. The exposure of these cells to G418 targeted ELAVL1/HuR into cytoplasm in more than 60% of the wild type cells. This effect was reversed with the addition of Cbl ( Figure 2B ). In contrast, in CblG fibroblasts, ELAVL1/HuR was localized to both the nucleus and cytoplasm, and this subcellular distribution pattern could not be modified further by the addition of G418 ( Figure 2B ). These results suggested that the nucleocytoplasmic shuttling of ELAVL1/HuR was partially blocked in CblG fibroblasts (even under ER stress with the presence of G418). In mice, the subcellular localization of ELAVL1/HuR changed with age. At 7 weeks old, no difference between wild type and Cd320 KO mice was observed in ELAVL1/HuR subcellular distribution in brain, both being nuclear-bound. This changed with age; at 40 weeks in several neuronal types such as hippocampal neurons, ELAVL1/HuR was predominantly cytoplasmic in wild type mice, in contrast to the nuclear localization observed in Cd320 KO mice ( Figure 2C ). Thus, we suggested that in WT mice the physiological stress of ageing is the driving force for ELAVL1/HuR export into the cytoplasm. In wild type neurons, ELAVL1/HuR successfully shuttled into the cytoplasm to exert anti-stress response. However, in Cd320 KO mice, this failed due to the dysregulated ELAVL1/HuR export.
The disruption of ELAVL1/HuR export triggered the nuclear retention of ELAVL1/HuR-specific AU-rich RNA including Sirt1 mRNA
We subsequently asked whether the altered distribution of ELAVL1/HuR could block the nucleocytoplasmic mRNA transport in general and in particular Sirt1. Using degenerated RNA probes designed for ELAVL1/HuR (23), we observed a higher labeling intensity of the ELAVL1/HuRspecific AU-rich RNAs in the nucleus of TO versus OT In mice model, ELAVL1/HuR localization altered with age. In young animal, no difference was noted on the nuclear localization of ELAVL1/HuR; with age due to aging stress, in wild type mice ELAVL1/HuR became localized to the cytoplasm while in KO mice, ELAVL1/HuR remained nuclear. Here, hippocampal neurons were used to illustrate the mislocalization associated with aging stress of the Cd320 mice. cells ( Figure 3A) . Consistent with this, significant transcriptomic changes in TO versus OT cells involved the known targets of ELAVL1/HuR (http://starbase.sysu.edu). In fact, among the 2447 orthologous ELAVL1/HuR targets in mouse, the transcription of as much as 82% of them were altered in TO versus OT cells (Supplementary Figure  S2) . The top functional annotations of these genes were related to RNA transport, ER stress, neuroplasticity, protein acetylation and cell cycle (Supplementary Figure S2 , Supplementary Table S1 ). These results suggested that the cellular Cbl deficit caused nuclear sequestration of the AU-rich RNAs through impaired export of ELAVL1/HuR. Among the AU-rich targets of ELAVL1/HuR, we examined in particular the Sirt1 transcript as we previously found decreased SIRT1 expression in TO versus OT cells (5) . We performed RNP immunoprecipitation (RIP) of ELAVL1/HuR and we found a slight decrease of the amount of ELAVL1/HuRbound Sirt1 mRNA in TO versus OT cells ( Figure 3B ). It should be noted that the real difference in the amount of cytoplasmic Sirt1 mRNA bound to ELAVL1/HuR between TO and OT cells was underestimated since whole cell lysates were used for the RIP. The treatment of TO cells with SAM had no significant effect on the binding of ELAVL1/HuR to Sirt1 mRNA. In agreement with this finding, AdoX had no effect in OT cells. These results showed therefore that the methylation of ELAVL1/HuR has a limited influence, if any, on the amount of ELAVL1/HuR-bound Sirt1 mRNA in TO versus OT cells. In contrast, the treatment of TO cells with Okadaic acid, an inhibitor of protein phosphatase 2 (PP2A) increased the binding of ELAVL1/HuR to Sirt1 mRNA. The effect of Okadaic acid suggests that the increased phosphorylation of ELAVL1/HuR may increase its binding to Sirt1 mRNA. Conversely, the decreased phosphorylation of ELAVL1/HuR may explain the slight de- creased of its binding to Sirt1 mRNA in TO versus OT cells ( Figures 1C and 3B) . To confirm the role of ELAVL1/HuR on Sirt1 expression, Elavl1 was knocked down using siRNA technique. The siElavl1 reduced both ELAVL1/HuR and SIRT1 protein expressions in TO and OT cells ( Figure 3C ). Providing quantifications assessing the effect of knocking ELAVL1/HuR on Sirt1 protein levels was not possible due to its very low levels in untreated TO cells ( Figure 3C ).
ELAVL1/HuR mRNA export was blocked by Cbl impaired metabolism through altered interactions of ELAVL1/HuR with its partners of the nuclear pore complex (NPC)
To dissect the molecular mechanisms of the ELAVL1/HuR-dependent mRNA export block, we tested whether Cbl deficiency altered the interactions of ELAVL1/HuR with its partners of NPC. In NPC, ELAVL1/HuR recruits CRM1/exportin via the adaptor proteins IPP2A and APRIL to shuttle the AU-rich element (ARE)-containing mRNAs (24) . In Cd320 KO versus WT mice, we found that less CRM1, I1PP2A, I2PPA and APRIL, and more PP2A proteins co-immunoprecipitated with ELAVL1/HuR ( Figure 4A and Supplementary Figure   S4 ). The same difference was obtained in the co-IP of TO versus OT cells ( Figure 4B ). Two ELAVL1/HuR partners, I1PP2A and I2PP2A, were practically missing, and CRM1 and APRIL were significantly decreased in TO cells ( Figure  4B and Supplementary Figures S4, S5 ). This was due in part to their decreased expression in TO cells ( Figure 4C and Supplementary Figure S4) . The reduced interaction of ELAVL1/HuR with CRM1 was counterbalanced by its interaction with PP2A ( Figure 4B and Supplementary  Figures S4 and S5) . Treating TO cells with Cbl or SAM restored the expression of ELAVL1/HuR partners ( Figure  4C ). Decreasing PP2A expression via siPpp2ca restored the interaction of ELAVL1/HuR with CRM1/exportin, while decreasing CARM1 expression via siCarm1 produced the opposite effect ( Figure 4B and Supplementary Figure S5 ). The increased expression of wild type PP2A by transfection in OT cells decreased the binding of APRIL to ELAVL1/HuR, showing that the interaction was affected by PP2A-mediated ELAVL1/HuR dephosphorylation ( Figure 4D and Supplementary Figure S5) .
Using Duolink (proximity ligation assay, PLA) we further studied the interaction between ELAVL1/HuR and CRM1, and the nucleocytoplasmic localization of ELAVL1/HuR in fibroblasts of normal subject and patients with CblC (mutation of MMACHC), CblG (mutation of MTR), and CblG-variant inherited disorders. We observed a substantial decrease in ELAVL1/HuR-CRM1 interaction in the nucleus of patients vs. normal cells (Figure 5) . Taken together these data indicated that cellular Cbl deficit in both cell and animal model disrupted the interaction of ELAVL1/HuR with CRM and its partners of NPC through PP2A-and CARM1-dependent mechanisms.
The disruption of ELAVL1/HuR shuttling by Cbl cellular deficiency was both SAM-and methylation-dependent
As Cbl serves for the de novo synthesis of methionine and, hence, for SAM, we asked if disrupted ELAVL1/HuR shuttling was the consequence of decreased SAM level in TO cells and patients' fibroblasts. We observed in TO cells but not OT cells a large reduction in the percentage of cells with nuclear ELAVL1/HuR staining when adding either Cbl or SAM ( Figure 6A and B) . Conversely, incubation of OT cells with SAM inhibitor AdoX led to ELAVL1/HuR nuclear retention ( Figure 1A) . The same treatment of TO cells produced no extra effect. The Duolink proximity ligation assay of methyl-ELAVL1/HuR with antibodies against methyl-arginine and ELAVL1/HuR revealed that its localization was cytoplasmic ( Figure 6C ). CARM1 is known to catalyze the methylation of ELAVL1/HuR R217 (25) . We used a custom-made affinity-purified antibody against methyl R217 ELAVL1/HuR and a methylated peptide described previously (25) to answer whether cellular Cbl deficiency produced a R217 demethylated ELAVL1/HuR. Indeed, Western blots revealed lower methyl R217 ELAVL1/HuR level in TO versus OT cells ( Figure 7A ). The addition of either Cbl or SAM to TO cells rescued the expression of methyl R217 ELAVL1/HuR ( Figure 7A and Supplementary Figure S6) . Results of the immunofluorescence stainings with anti-methyl R217 ELAVL1/HuR in the presence of blocking peptide, either methylated or non-methylated, indicated that methyl R217 ELAVL1/HuR resided only in the cytoplasmic compartment of both TO and OT cells ( Figure 7B ). Data from knocking down CARM1 with siCarm1 confirmed its involvement in ELAVL1/HuR cytoplasmic export ( Figure  7C, Supplementary Figure S6) . Together, the evidence showed that the decreased CARM1-dependent methyla- The presence of non-methylated ELAVL1/HuR in both cytoplasm and nucleus (see Figure 7B , TO versus OT in the presence of blocking methylated peptide) suggested that a second mechanism could influence the export of nonmethylated ELAVL1/HuR. Recent data from the literature suggest that ELAVL1/HuR interacts with PP2A phosphatase (26) and that Cbl deficiency or DNA hypomethylation can lead to over-expression of PP2A (8, 27) . Consistently, we observed that the level of methylated and demethylated PP2A protein varied in a Cbl-and SAMdependent manner in TO cells ( Figure 8A ). The Duolink assay shown in Figure 8B revealed that the impaired Cbl availability in TO cells reduced ELAVL1/HuR serine phosphorylation. This result was consistent with the Western blot of ELAVL1/HuR immunoprecipitated with an anti-phosphoserine antibody ( Figure 1C ). Both PP2A and ELAVL1/HuR were co-localized to the nucleus of TO cells and both were predominantly detected in the cytoplasm of OT cells ( Figure 8C ). The application of either PP2A inhibitor okadaic acid or knockdown of PP2A by siPpp2ca independently changed the localization of both PP2A and ELAVL1/HuR from nucleus to cytoplasm in TO cells. This did not occur in OT cells ( Figure 8C ). The demethyl-PP2A was found in both nucleus and cytoplasm in TO cells while methyl-PP2A was mainly cytoplasmic ( Supplementary Figure S6) . Numerous serine phosphorylation sites have been previously identified in ELAVL1/HuR (28) . We focused our attention here on S221 phosphorylation for two reasons: (a) S221 is located in the nucleocytoplasmic shuttling (HNS) domain of ELAVL1/HuR, and (b) PKC␣ and PKC␦ have altered expression in TO versus OT cells ( Figure  1D ) and are both implicated in S221 phosphorylation. The decreased phosphorylation of ELAVL1/HuR in TO cells ( Figure 1C ) was consistent with the decreased expression of serine kinases, PKC␣ and PKC␦ and the increased expression of PP2A ( Figure 1D and Supplementary Figure  S4) . To decipher the respective and combined role of R217 methylation and S221 phosphorylation on ELAVL1/HuR shuttling, we created S221A, S221D, R217A single mutations and R217A-S221A and R217A-S221D double mutations in a human ELAVL1/HuR construct (29) and we overexpressed them in control OT cells. Transfection with R217A and S221A single mutants and R217A-S221A double mutants all led to fewer cells with cytoplasmic-only ELAVL1/HuR staining than those observed in mock transfected OT cells (Supplementary Figure S7) . These results suggested that R217 methylation and S221 phosphorylation independently regulate the subcellular localization of ELAVL1/HuR. This conclusion was corroborated by the immunofluorescence staining of the R217A-S221D double mutant with only cytoplasmic staining in most of the transfected OT cells. However, it is worth noting that S221 phosphorylation alone is probably not sufficient for triggering ELAVL1/HuR export in regard to the results obtained by S221D overexpression in TO versus OT cells (Supplementary Figure S7 ).
The arginine-methylation and serine-phosphorylation of ELAVL1/HuR were also impaired in fibroblasts of patients with CblC and CblG inborn errors of Cbl metabolism
Duolink proximity ligation assay of the fibroblasts from patients with CblC and CblG inherited disorders showed also decreased protein arginine-methylation and protein serinephosphorylation of ELAVL1/HuR ( Figure 9A ). These results were confirmed by Western blots on immunoprecipitated ELAVL1/HuR protein using antibodies against methyl-arginine and phosphoserine in CblC and CblG fibroblasts. The treatment of CblC and CblG fibroblasts with PP2A inhibitor okadaic acid restored the serine phosphorylation of ELAVL1/HuR, and the treatment with Adox blocked the methylation of ELAVL1/HuR ( Figure 9B ). In contrast to ELAVL1/HuR, Y14 is not mislocalized and is neither phosphorylation nor methylation in patient fibroblasts (Supplementary Figure S8) . Taken together, these data showed that similar mechanisms as those observed in both cell and animal models regulate ELAVL1/HuR shuttling in fibroblasts of patients with CblC and CblG inherited disorders of Cbl metabolism.
DISCUSSION
The mechanisms at the origin of the highly variable clinical presentation of inherited Cbl disorders are far from being understood (1, 2) . Part of the explanation may lie in the complexity of dysregulated methylation dependent signaling pathways downstream of Cbl deficiency. In fibroblasts of patients with Cbl inborn errors, the production of reactive oxygen species (ROS) has been found increased and the defense against oxidant stress decreased (28,29). In Cbl deficient cell and animal models, ER stress has also been evidenced downstream of reduced SAM synthesis and SIRT1 activity (5 protein arginine-methylation and serine-phosphorylation. ELAVL1/HuR, a key regulator of neuronal stress, is the most affected RBP, and its mislocalization hinted disrupted export of AU-rich element (ARE)-containing mRNA targets from nucleus to cytoplasm. We indeed observed dramatic transcriptomic changes related to stress response. More importantly, the gene functions related to neurogenesis, synapse transmission, brain development, and neuroplasticity are equally touched. Remarkably, these alterations are consistent with the neurological manifestations associated with both Cbl deficiency and Cbl inherited diseases (1,2). Cobalamin deficiency additionally caused cytoplasmic accumulation of hnRNPA1, a RBP known to be responsive to osmotic shock stress and capable of shuttling between nucleus and cytoplasm. Our evidence suggests this to be linked to dysregulated serine phosphorylation at the C-terminal domain of the protein which blocked its nuclear importation (30) . Equally important is the mislocalization of Y14 and SRSF1. As these proteins participate in constitutive and alternative splicing needed to maintain cellular homeostasis, survival, and DNA repair, their mislocalization weakens cellular stress response to DNA damage, oxidative stress, and perturbed one-carbon metabolism. Given the number of RBPs examined that are mislocalized in the N1E115 cells, this dysregulation of RNA metabolism may represent a prominent mechanism associated with the neurological manifestations of inherited disorders of cobalamin metabolism metabolic diseases.
It is worth noting that to deprive the intracellular Cbl, the neuronal cell model N1E115 has to be grown in the presence of G418 to maintain the stable expression of transgene TC-Oleosin (TO) or Oleosin-TC (OT). It is with the presence of G418, ELAVL1/HuR is confined to the nucleus in Cbl-deficient TO cells, in contrast to the cytoplasmic localization observed in OT cells. This indicates that while under stress in non-deficient cells, ELAVL1/HuR can be exported to the cytoplasm, in Cbl deficient cells the exportation is blocked. Interestingly, cellular stress -manifested downstream often in the form of oxidative and ER stress -is an integral part of disease mechanisms, affecting maladies like inborn errors of Cbl metabolism. Cellular stress is expected to trigger ELAVL1/HuR export from nucleus to cytoplasm. Considering that ELAVL1/HuR export is also altered in patient fibroblasts and in hippocampal neurons of the Cd320 KO mice (the experimental systems without the presence of G418), we conclude that cellular response to stress mediated by ELAVL1/HuR-containing hnRNP complex shuttling is impaired in both human and mouse under aberrant Cbl metabolism. Together with the previous evidence that in TO and OT model cell system, cellular Cbl deficit produced non-adapted unfolded protein response due to decreased SIRT1 activity (5, 13, 31) , our data here provide a mechanistic link between anti-stress responses mediated by ELAVL1/HuR and SIRT1 activity. A major consequence of ELAVL1/HuR nuclear retention is the confinement of ELAVL1/HuR target mRNAs like Sirt1 in the nucleus, hence reduced translation of ELAVL1/HuRrelevant stress response proteins. A decreased expression and activity of SIRT1 is a key component of the nonadapted response to the ER stress of the TO cells and the rats subjected to Cbl and folate deficient diet (5, 12, 13, 31) , as reduced SIRT1 protein expression leads to HSF1 hyperacetylation, the latter in turn reduces the expression of heat shock proteins (HSPs) (32) . Besides HSPs, other gene function may also be affected as decreased SIRT1activity can contribute to dysregulated nuclear receptor co-regulation via deacetylated PGC1␣, as observed in the brain, heart and gut of rats deficient in Cbl and folate (10) (11) (12) (13) (14) 31) . We traced the cause of the disrupted ELAVL1/HuR exportation to altered post translational methylation and phosphorylation of ELAVL1/HuR that affect the affinity of ELAVL1/HuR to its nuclear receptor CRM1/exportin. CRM1/exportin is a general export receptor that mediates ARE-containing mRNAs export in the cytoplasm (33) . Under Cbl deficiency, the binding of ELAVL1/HuR to CRM1/exportin and to other partners of the NPC machinery like I1PP2A and APRIL (33, 34) were found all reduced. Furthermore, we found that in N1E115 TO/OT cell model, while R217 methylation helps to localized ELAVL1/HuR to the cytoplasm, serine dephosphorylation of demethylated ELAVL1/HuR causes its nuclear retention. These changes in post translation modifications of EVAVL1/HuR correlate with decreased levels of SAM, CARM1 and PKCs, and increased level of PP2A, all resulting from of perturbed Cbl metabolisms. The altered phosphorylation of ELAVL1/HuR was influenced by PP2A and the subsequent disruption of the interaction between ELAVL1/HuR and CRM1/exportin could be reversed by Cbl and siPpp2ca cell transfection. These data are consistent with the upregulation of PP2A previously observed in TO versus OT cells (8) . The methylation of ELAVL1/HuR on the R217 residue has been shown to increase its association to Sirt1 mRNA (35, 36) . The effect of impaired cobalamin metabolism on the methylation of ELAVL1/HuR and the decreased expression of Sirt1 in TO cells could be accounted for by the decreased binding of ELAVL1/HuR to the Sirt1 mRNA, and not only due to its localization. However, this mechanism may have a limited influence in TO and OT cells, since SAM and AdoX had no significant effect on the binding of ELAVL1/HuR to Sirt1 mRNA.
The non-adapted response to ER stress produced by ELAVL1/HuR nuclear retention and the related impaired export of mRNAs may be part of the puzzle explaining the wide spectrum of clinical neurological manifestations of nutritional and inherited causes of Cbl deficiency. The transcriptomic changes in the cell model reported here are consistent with most of the clinical neurological manifestations of Cbl deficiency, with some of them related to brain development, affecting genes controlling cell cycle, apoptosis and differentiation and some to late stage neurological manifestations including genes involved in ER stress, neuroplasticity and myelin synthesis (8, 13, 14) . The association of Cbl with abnormal brain ageing and neurodegeneration is consistent with the results of transcriptome indicat-NAs, most prominently via ELAVL1/HuR. This new insights shall help in the near future the reexamination of the pathological consequences on developmental and ageing processes caused by Cbl deficiency and Cbl inborn error and in the search for innovative therapies for inherited disorders of Cbl metabolism.
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